NCT02197234 2025-11-20
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed
AstraZeneca
Barbara Ann Karmanos Cancer Institute
University of Pennsylvania
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins